Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Gross Margin: 2021-2025

Historic Gross Margin for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to 99.51%.

  • Immunocore Holdings' Gross Margin rose 6.00% to 99.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 99.29%, marking a year-over-year increase of 16.00%. This contributed to the annual value of 99.12% for FY2024, which is 46.00% down from last year.
  • Per Immunocore Holdings' latest filing, its Gross Margin stood at 99.51% for Q3 2025, which was up 0.57% from 98.94% recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Gross Margin peaked at 100.00% during Q4 2021, and registered a low of 97.74% during Q2 2024.
  • For the 3-year period, Immunocore Holdings' Gross Margin averaged around 99.30%, with its median value being 99.51% (2025).
  • As far as peak fluctuations go, Immunocore Holdings' Gross Margin slumped by 168bps in 2024, and later spiked by 120bps in 2025.
  • Over the past 4 years, Immunocore Holdings' Gross Margin (Quarterly) stood at 100.00% in 2021, then reached 99.71% in 2023, then dropped by 11bps to 99.61% in 2024, then climbed by 6bps to 99.51% in 2025.
  • Its last three reported values are 99.51% in Q3 2025, 98.94% for Q2 2025, and 99.11% during Q1 2025.